| Literature DB >> 28195222 |
T F Cardoso1,2, A Cánovas1, O Canela-Xandri3, R González-Prendes1, M Amills1,4, R Quintanilla3.
Abstract
We have used a RNA-seq approach to investigate differential expression in the skeletal muscle of swine (N = 52) with divergent lipid profiles i.e. HIGH (increased intramuscular fat and muscle saturated and monounsaturated fatty acid contents, higher serum lipid concentrations and fatness) and LOW pigs (leaner and with an increased muscle polyunsaturated fatty acid content). The number of mRNAs and non-coding RNAs (ncRNAs) expressed in the porcine gluteus medius muscle were 18,104 and 1,558, respectively. At the nominal level of significance (P-value ≤ 0.05), we detected 1,430 mRNA and 12 non-coding RNA (ncRNA) transcripts as differentially expressed (DE) in the gluteus medius muscle of HIGH vs LOW pigs. This smaller contribution of ncRNAs to differential expression may have biological and technical reasons. We performed a second analysis, that was more stringent (P-value ≤ 0.01 and fold-change ≥ 1.5), and only 96 and 0 mRNA-and ncRNA-encoding genes happened to be DE, respectively. The subset of DE mRNA genes was enriched in pathways related with lipid (lipogenesis and triacylglycerol degradation) and glucose metabolism. Moreover, HIGH pigs showed a more lipogenic profile than their LOW counterparts.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28195222 PMCID: PMC5307323 DOI: 10.1038/srep40005
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
List of the most significant differentially expressed genes in HIGH and LOW pigs after correcting for multiple testing (q-value ≤ 0.05 and fold-change ≥ 1.5).
| Ensembl ID | Gene name | Fold-Change | ||
|---|---|---|---|---|
| ENSSSCG00000005648 | 1.66 | 1.32E-06 | 4.28E-03 | |
| ENSSSCG00000027946 | 1.78 | 2.63E-06 | 5.97E-03 | |
| ENSSSCG00000017232 | 1.72 | 1.26E-05 | 1.36E-02 | |
| ENSSSCG00000005935 | 1.59 | 1.77E-05 | 1.43E-02 | |
| ENSSSCG00000003379 | 1.79 | 1.61E-05 | 1.43E-02 | |
| ENSSSCG00000011740 | −1.81 | 2.48E-05 | 1.72E-02 | |
| ENSSSCG00000001931 | −1.58 | 2.74E-05 | 1.76E-02 | |
| ENSSSCG00000011444 | 1.54 | 3.26E-05 | 1.76E-02 | |
| ENSSSCG00000007574 | 1.58 | 2.97E-05 | 1.76E-02 | |
| ENSSSCG00000007745 | −1.54 | 4.21E-05 | 1.95E-02 | |
| ENSSSCG00000000293 | 1.72 | 4.46E-05 | 1.96E-02 | |
| ENSSSCG00000007133 | 1.51 | 5.18E-05 | 2.09E-02 | |
| ENSSSCG00000028814 | 1.97 | 5.37E-05 | 2.09E-02 | |
| ENSSSCG00000006277 | 2.04 | 5.90E-05 | 2.19E-02 | |
| ENSSSCG00000007554 | 2.54 | 1.01E-04 | 2.88E-02 | |
| ENSSSCG00000003105 | 1.67 | 1.17E-04 | 3.07E-02 | |
| ENSSSCG00000010529 | 2.03 | 1.31E-04 | 3.11E-02 | |
| ENSSSCG00000006245 | 3.02 | 1.36E-04 | 3.15E-02 | |
| ENSSSCG00000013579 | 1.95 | 1.50E-04 | 3.31E-02 | |
| ENSSSCG00000008232 | −2.09 | 2.05E-04 | 3.57E-02 | |
| ENSSSCG00000030165 | 1.67 | 2.22E-04 | 3.72E-02 |
A negative FC means that the affected gene is overexpressed in LOW pigs.
IPA-based pathway analysis of the list of genes that are differentially expressed in HIGH and LOW pigs (P-value ≤ 0.01 and fold-change ≥ 1.5).
| Ingenuity Canonical Pathways | − | Ratio | Nodes |
|---|---|---|---|
| Acute Myeloid Leukemia Signaling | 3.22 | 4/91 | |
| Hematopoiesis from Pluripotent Stem Cells | 2.98 | 3/47 | |
| Primary Immunodeficiency Signaling | 2.96 | 3/48 | |
| Hepatic Fibrosis/Hepatic Stellate Cell Activation | 2.12 | 4/183 | |
| TR/RXR Activation | 2.08 | 3/98 | |
| Palmitate Biosynthesis I (Animals) | 2.07 | 1/2 | |
| Fatty Acid Biosynthesis Initiation II | 2.07 | 1/2 | |
| CTLA4 Signaling in Cytotoxic T Lymphocytes | 2.07 | 3/99 | |
| Retinoate Biosynthesis I | 2.04 | 2/34 | |
| Stearate Biosynthesis I (Animals) | 2.02 | 2/35 |
Ratio: number of DE genes in a pathway divided by the number of genes comprised in the same pathway.
Figure 1The top-scoring regulatory network identified with the IPA software corresponded to Cardiovascular Disease, Cardiovascular System Development and Function, Organismal Injury and Abnormalities.
Genes that are upregulated and downregulated in HIGH pigs (when compared with the LOW ones) are displayed within red and green nodes, respectively. Solid and dashed lines between genes represent known direct and indirect gene interactions, respectively. The shapes of the nodes reflect the functional class of each gene product: transcriptional regulator (horizontal ellipse), transmembrane receptor (vertical ellipse), enzyme (vertical rhombus), cytokine/growth factor (square), kinase (inverted triangle) and complex/group/other (circle).
Figure 2The Regulator Effects tool of the IPA package was employed to identify two major upstream regulators (PPARG and PDGFB) of the networks of differentially expressed genes.
This tool integrates Upstream Regulator results with Downstream Effects results to build causal hypotheses that help to interpret what may be occurring upstream to cause particular phenotypic or functional outcomes downstream (http://www.ingenuity.com/products/ipa/ipa-spring-release-2014). In the upper tier, there are two upstream regulators (PPARG and PDGFB) predicted to be activated (orange color). In the middle tier, we can see the genes whose expression changes in response to the activation of upstream regulators (red = upregulation). The shapes of the nodes reflect the functional class of each gene product: enzyme (vertical rhombus), transcription regulator (vertical ellipse), cytokine/growth factor (square), ligand-dependent nuclear receptor (horizontal rectangle) and complex/group/other (circle). In the lower tier, the expected phenotypic consequences of changes in gene expression are shown by considering the Ingenuity Knowledge Base (absolute z-score > 2 and P-value < 0.05). The octagonal symbol defines Function, while solid and dashed lines between genes represent known direct and indirect gene interactions, respectively. Orange leads to activation, while blue leads to inhibition predicted relationships. Orange (predicted to be activated) and blue (predicted to be inhibited) lines represent relationships with causal consistency.
Evolutionary conservation of non-coding RNAs transcribed in the porcine gluteus medius muscle.
| Transcript | Transcript Type | Number | Conserved ncRNA |
|---|---|---|---|
| miRNA | 433 | 137 | |
| misc_RNA | 95 | 82 | |
| Mt-rRNA | 2 | 0 | |
| Mt-tRNA | 22 | 0 | |
| rRNA | 57 | 52 | |
| snoRNA | 417 | 395 | |
| snRNA | 328 | 273 | |
| Non coding | 4 | 0 | |
| Processed transcript | 143 | 0 | |
| Antisense | 15 | 0 | |
| lincRNA | 42 | 0 |
miRNA = microRNAs; misc_RNA = miscellaneous other RNA; Mt-rRNA = Mitochondrial ribosomal RNA; Mt-tRNA = transfer RNA located in the mitochondrial genome; rRNA = ribosomal RNA; snoRNA = small nucleolar RNA; snRNA = small nuclear RNA; lincRNA = Long intergenic non-coding RNAs.
List of non-coding RNAs that are differentially expressed (at the nominal level, P-value ≤ 0.05) in the gluteus medius muscle of HIGH and LOW pigs.
| Ensembl ID | Gene ID | Size (bp) | Fold Change | Type of ncRNA | |
|---|---|---|---|---|---|
| ENSSSCG00000031004 | 1833 | −1.44 | 0.002 | lincRNA | |
| ENSSSCG00000031028 | 1495 | −1.34 | 0.014 | lincRNA | |
| ENSSSCG00000015579 | 3601 | −1.47 | 0.016 | Processed transcript | |
| ENSSSCG00000030904 | 1083 | −1.49 | 0.025 | Non coding | |
| ENSSSCG00000001227 | 1767 | −1.31 | 0.026 | Processed transcript | |
| ENSSSCG00000030767 | 1147 | −1.29 | 0.027 | Processed transcript | |
| ENSSSCG00000015549 | 2716 | −1.87 | 0.028 | Processed transcript | |
| ENSSSCG00000018090 | 70 | −2.05 | 0.036 | Mt-tRNA | |
| ENSSSCG00000001397 | 1726 | −1.27 | 0.038 | Processed transcript | |
| ENSSSCG00000001227 | 1700 | −1.3 | 0.043 | Processed transcript | |
| ENSSSCG00000004334 | 2818 | −1.72 | 0.044 | Processed transcript | |
| ENSSSCG00000015897 | 3720 | −1.6 | 0.046 | Processed transcript |
A negative FC means that the affected gene is overexpressed in LOW pigs; lincRNA = Long intergenic non-coding RNAs, Mt-tRNA = transfer RNA located in the mitochondrial genome.
Protein-encoding genes that map near (30 kb) to the subset of 12 differentially expressed ncRNAs (HIGH vs LOW pigs).
| Non-coding RNA | Neighboring mRNA gene | Fold Change | RPKM-means LOW | RPKM-means HIGH | |
|---|---|---|---|---|---|
| −1.02 | 0.500 | 10.70 | 10.50 | ||
| −1.03 | 0.435 | 8.97 | 8.69 | ||
| −1.07 | 0.461 | 0.35 | 0.33 | ||
| 1.40 | 1.77 | ||||
| 1.10 | 0.020 | 12.60 | 13.90 | ||
| 1.24 | 0.316 | 0.09 | 0.11 | ||
| −1.03 | 0.777 | 1.88 | 1.84 | ||
| −1.04 | 0.865 | 2.82 | 2.72 | ||
| 1.07 | 0.587 | 0.08 | 0.08 | ||
| −1.15 | 0.024 | 5019.58 | 4372.26 | ||
| −1.13 | 0.033 | 25335.60 | 22504.43 | ||
| 5199.05 | 4287.84 | ||||
| −1.12 | 0.051 | 20299.35 | 18062.05 | ||
| −1.16 | 0.051 | 3264.12 | 2809.24 | ||
| −1.13 | 0.064 | 24826.52 | 21886.25 | ||
| −1.10 | 0.086 | 4413.22 | 4010.71 | ||
| −1.10 | 0.123 | 10033.49 | 9149.34 | ||
| −1.07 | 0.162 | 6421.54 | 5974.98 | ||
| −1.08 | 0.164 | 31328.03 | 28896.14 | ||
| −1.06 | 0.197 | 8412.34 | 7957.73 | ||
| −1.04 | 0.243 | 5784.35 | 5564.63 | ||
| −1.03 | 0.289 | 2042.94 | 1980.50 | ||
| −1.10 | 0.665 | 2.56 | 2.33 | ||
| 2.22 | 0.300 | 0.11 | 0.24 | ||
| −1.17 | 0.123 | 79.31 | 67.50 |
Differentially expressed ncRNAs and mRNAs (HIGH vs LOW pigs) P-value ≤ 0.05, Fold Change ≥ 1.2) are shown in bold. A negative Fold Change means that the affected gene is overexpressed in LOW pigs.